Jim Cramer: Allergan Won’t Pick Up Valeant Pieces

Allergan CEO Brent Saunders will not bounce back from his company's failed merger with Pfizer (PFE) - Get Report by purchasing Valeant (VRX) , said TheStreet's Jim Cramer. He said Allergan's chief flatly ruled out getting involved with Valeant, which has been slammed due to accounting woes. Allergan has a different tax domicile, so Cramer said it will do something constructive and it's shares should be bought, but it won't be doing anything with Valeant.

At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.